Immune Pharmaceuticals Signs Agreement to Fund Maxim Pharmaceuticals,...

2016-09-16T09:24:10-07:00

NEW YORK, Sept. 16, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP) (“Immune” or the “Company”), a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of ...